Cargando…

Editorial: Functional Nanomaterials in Inflammatory Diseases: From Prevention to Diagnosis and Therapy

Detalles Bibliográficos
Autores principales:	Evans, Colin E., Jin, Hua, Pi, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661447/ https://www.ncbi.nlm.nih.gov/pubmed/34899359 http://dx.doi.org/10.3389/fphar.2021.802633

Ejemplares similares

Cationic Nanomaterials for Autoimmune Diseases Therapy
por: Xie, Baozhao, et al.
Publicado: (2022)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Editorial: Prevention, diagnosis and treatment of rare disorders
por: Cox, Timothy M., et al.
Publicado: (2022)

Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
por: Liu, Zhichao, et al.
Publicado: (2020)

Therapeutic Applications of Functional Nanomaterials for Prostatitis
por: Liu, Chun-Ping, et al.
Publicado: (2021)

Editorial: Nanomaterials for the diagnosis and therapy of viral infections
por: Bardi, Giuseppe, et al.
Publicado: (2023)

Editorial: Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy With Biologics
por: Giuliani, Anna Lisa, et al.
Publicado: (2021)

Editorial: Sex Differences in Inflammatory Diseases
por: Trabace, Luigia, et al.
Publicado: (2022)

Editorial: Thyroid cancer: New perspectives in diagnosis and therapy
por: Sarkar, Rhitajit, et al.
Publicado: (2022)

Editorial: Traditional medicine and chronic inflammatory diseases
por: Liu, Wei, et al.
Publicado: (2023)

Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy
por: Qin, Weiwei, et al.
Publicado: (2017)

Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
por: Giuliani, Anna Lisa, et al.
Publicado: (2023)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Editorial: Use of small peptides in the treatment of inflammatory diseases
por: Chemtob, Sylvain, et al.
Publicado: (2022)

Editorial: Big data for biomedical research of inflammatory diseases
por: Mao, Jingxin, et al.
Publicado: (2023)

Editorial: Functional Nanomaterials for Cancer Diagnostics and Therapy
por: Chen, Wansong, et al.
Publicado: (2021)

Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
por: Hao, Xinyan, et al.
Publicado: (2022)

The applications of functional materials-based nano-formulations in the prevention, diagnosis and treatment of chronic inflammation-related diseases
por: Wang, Jingjing, et al.
Publicado: (2023)

Editorial: Efficacy and mechanism of herbal medicines and their functional compounds in preventing and treating cardiovascular diseases and cardiovascular disease risk factors
por: Meng, Tiantian, et al.
Publicado: (2023)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment
por: Li, Shuang, et al.
Publicado: (2021)

Editorial: New trends in natural product research for inflammatory and infectious diseases
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2022)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions
por: Li, Yanping, et al.
Publicado: (2022)

Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021)

Editorial: Circadian biology, cardiovascular function and disease
por: Chong, Nelson, et al.
Publicado: (2023)

Editorial: Drug Hypersensitivity: From Mechanisms to Improved Diagnosis and Standards of Care
por: Fernandez, T. D., et al.
Publicado: (2021)

Editorial: Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Theraphy Development
por: Liu, Zhichao, et al.
Publicado: (2022)

Editorial: Adaptive immune resistance in cancer therapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Editorial: Anti-Inflammatory Agents in the Context of Age-Related Cardiometabolic Disease: Ethnopharmacological Perspectives
por: Arumugam, Somasundaram, et al.
Publicado: (2022)

Editorial: Advances in inflammatory bowel disease: Mucosal defense mechanisms against gut inflammation
por: Corr, Sinéad C., et al.
Publicado: (2023)

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2023)

Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms
por: Ramprasath, Tharmarajan, et al.
Publicado: (2022)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics
por: Jiang, Lin-Hua, et al.
Publicado: (2021)

Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury
por: Jin, Hua, et al.
Publicado: (2021)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Editorial: Role of Blood Cells in Inflammatory and Vascular Disorders
por: Brancaleone, Vincenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mjg10jedir6od66b6ed6eknhp2